Review

Is radical cystectomy the gold standard?

• Binhan Kağan Aktaş
• Ali Memiş

Bladder cancer epidemiology in the world and in Tukey

• Sultan Eser
• Raziye Özdemir

Prognostic factors in renal cancer and prediction models

• Ümit Gül
• Özgür Yaycıoğlu

Robotic surgery in radical cystectomy

• Yakup Kordan
• Burhan Coşkun

Geometry of cancer and fractals in bladder cancer

• Fehmi Narter
• Osman Köse

New approaches to assess the morphology of renal masses

• Barbaros Başeskioğlu
• Cavit Can

İntravezikal tedavilere yardımcı yöntemler

• Hüseyin Cihan Demirel

Positron Emission Tomography/Computed Tomography in Bladder Carcinoma

• Recep Bekiş
• Emine Acar
• Uğur Mungan

Prostate cancer, screening and diagnosis according to EAU and AUA 2013 updates and practical considerations

• Tünkut Doğanca
• Can Öbek

Second-TUR

• Ali Feyzullah Şahin
• Rauf Taner Divrik

The Risk Stratifications in Non-Muscle Invasive Bladder Cancer: How Much Accurate are the Methods That We Use? A Multi-Directional View

• Barış Kuzgunbay
• Yıldırım Bayazıt

Treatment of small renal masses: Where we are in 2011

• Mutlu Ateş
• Mustafa Karalar
• Engin Doğantekin

The role of surgery for high-risk prostate cancer

• Oktay Üçer
• Talha Müezzinoğlu

Radical Cystectomy in Elderly Patients: Predicting Complications and Mortality, Technical Aspects and Postoperative Care

• Uğur Kuyumcuoğlu
• Kaan Özdedeli

Lympadenectomy in prostate cancer

• Murat Koşan

Nutritional evaluation of patients who are candidate for radical cystectomy

• Osman Köse
• Öztuğ Adsan

Flüoresan sistoskopi ve tur'un geleceği var mı?

• Gökhan Özer

Which Patients Should Undergo Immediate or Deferred Cystectomy in Non-Muscle Invazive Bladder Cancer? Evaluation of...

• Şenol Tonyalı
• Mustafa Sertaç Yazıcı

Markers in upper urinary tract tumors

• Çağ Çal

Laparoscopic partial nephrectomy: Step by step

• Mert Günay
• Cenk Y. Bilen

The effect of trace elements in prostate cancer

• İlker Çelen
• Feriye Şenol
• Talha Müezzinoğlu

Endoscopic treatment of BPH

• Ünal Sert
• Özcan Kılıç

Limited-standard-extended lymphadenectomy in bladder cancer

• Hayrettin Şahin

Bipolar veya plazmakinetik enerji ile yapılan TUR-M operasyonlarının klasik metottan farkı var mı?

• Binhan Kağan Aktaş
• Mehmet Murat Baykam

Has DNA methylation any impact in prostate cancer diagnosis?

• Buket Kosova
• Rukiye Özel
• Çağdaş Aktan

In which fields intermittent androgen deprivation therapy can be used in 2014?

• Yasin Ceylan
• Bu¨lent Gu¨nlu¨soy

Metabolic Changes Developing During Urinary Intestinal Diversion after Radical Cystectomy

• Mehmet Remzi Erdem
• Feridun Şengör

Dev Ta Tümörde TUR nasıl Yapılmalıdır?

• Taylan Oksay

Surgery in metastatic renal cell carcinoma

• Volkan İzol
• Bülent Soyupak

Open surgery is still gold standard for radical prostatectomy

• Polat Türker
• Levent Türkeri

TUR'a bağlı mesane perforasyonu: tedavi ve izlem

• Kürsad Zengin
• Sinan Başay

Current role of open prostatectomy in Turkey

• Uğur Kuyumcuoğlu
• Kaan Özdedeli

Importance of mycobacteria in treatment of bladder tumor

• Esra Büber
• Selçuk Keskin
• N. Leyla Açan

Parsiyel sistektomiyi unuttuk mu?

• C. Serkan Gökkaya
• Ali Memiş

Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer

• Tayyar Alp Özkan
• Özdal Dillioğlugil

Nursing care following radical cystectomy and urinary diversion

• Cemile Ulubay Akkaya

KTP laser prostatectomy: is it still trendy?

• Ahmet Rüknettin Aslan
• Feridun Şengör

Kadın sistektomisinde histerektomi ve vajinal kaf çıkarma ayrılmaz bir parça mıdır? Neden?

• Süleyman Bulut

Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?

• Polat Türker
• Sinan Ekici

A critical analysis of surgical curative treatments options in localised prostate cancer: open, laparoscopic, and robotassisted radical prostatectomy

• Ender Özden
• Yakup Bostancı
• Yarkın Kamil Yakupoğlu

Diagnosis and management of the strictures after prostatectomy

• Murat Akand
• Serdar Göktaş

Genişletilmiş lenfadenektomi standart bir tedavi olmalı mı?

• Ömer Gökhan Doluoğlu
• Mehmet Karabakan

The role of 5α-reductase inhibitors on prevention and hormonal treatment of prostate cancer

• Bülent Öztürk
• Tufan Çiçek

Açık, laparoskopik ve robotik sistektomi: avantaj ve dezavantajları

• Bülent Altunoluk

Is TUR-B operations can be done in the office conditions by using local anesthesia

• Tansu Değirmenci
• Bülent Günlüsoy

Upper urinary tract urothelial cell carcinoma 2011

• Mehmet Yariş
• Özgür Uğurlu

Can Bladder be Preserved with TURB + Chemotherapy instead of Radical Surgery (Can we Preserve the Bladder from Cancer)

• Cavit Can

Are radiological imagings useful in diagnosis, treatment and follow-up of Benign Prostatic Hyperplasia?

• Umut Gönülalan
• Bülent Öztürk

Quality of Life after Radical Cystectomy and Diversion

• Gökhan Toktaş
• Emre Karabay

Could focal therapy in prostate cancer replace standard therapy in the future?

• Saadettin Y. Eskiçorapçı
• Cihan Toktaş

Cystectomy in view of history

• Osman Köse
• Hasan S. Sağlam

Bowel preparation before radical cystectomy

• Şakir Ongün
• Güven Aslan

How affected Active Surveillance the quality of life in low-risk localized prostate cancer?

• İlker Çelen
• Sinharib Çitgez
• Talha Müezzinoğlu

Sentinel Lymph Node Biopsy in Lymphadenectomy for Prostate Cancer

• Cenk Acar
• Henk van der Poel

How Can One Define the Surgical Quality of Radical Cystectomy?

• Mesut Altan
• Burhan Özdemir
• Burak Çıtamak
• Bülent Akdoğan
• Haluk Özen

What is the evidence-based ideal treatment of clinical locally advanced (cT3) prostate cancer?

• Asıf Yıldırım
• Erem Kaan Başok

Surgical Approaches in Patients with Metastatic Bladder Cancer: Metastasectomy and Palliative Cystectomy

• Utku Lokman
• Özgür Uğurlu

Active surveillance in low risk prostate cancer

• Ozan Bozkurt
• Ömer Demir

Magnetic Resonance - Transrectal Ultrasound Fusion Guided Prostate Biopsy

• Ömer Burak Argun
• Can Öbek
• Ali Rıza Kural

Approaches to Upper Urinary Tract Recurrences Following Radical Cystectomy

• Mehmet İlker Gökçe
• Sümer Baltacı

Treatment options in low-intermediate risk prostate cancer

• Saadettin Yılmaz Eskiçorapçı
• Deniz Bolat

Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy, the Factors Associated with Upstaging and its Effect on Outcome

• Polat Türker

Nomograms for prostate cancer: which and when to use

• Saadettin Eskiçorapçı
• Deniz Bolat

Are there any treatment option for metastatic prostate cancer refractory to docetaksel?

• Yaşar Bedük

Transurethral Resection of Bladder Cancer (TUR-B) for Non-Muscle Invasive Bladder Cancer: How to Reach Excellence?

• Mehmet İlker Gökçe
• Yaşar Bedük

Robot-assisted radical prostatectomy: Operative technique — step by step

• Bora Özveren
• Levent Türkeri

What is the best cutoff value of PSA in detection of prostate cancer

• Hakan Gemalmaz

Relationship Between Human Papilloma Virus and Bladder Cancer

• Osman İnci
• Ebru Taştekin
• Hakan Akdere

Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?

• Ali Furkan Batur
• Sinan Sözen

Surgical treatment and/or radiotherapy in high risk prostate cancer

• Fatih Bıçaklıoğlu
• Cenk Acar
• Sinan Sözen

Is Lymphadenectomy Necessary in the Surgical Treatment of Upper Urinary Tract Urothelial Carcinoma?

• Yakup Kordan
• Onur Kaygısız

Controversies in Radical Cystectomy: Meta-Analysis and Systemic Comparison of Open Surgery with Laparoscopic and Robotic Surgery

• Mehmet Kaynar
• Serdar Göktaş

Does Urinary Cytology Find the Value in the Detection and Follow-up of Urinary Bladder Cancer?

• Kutsal Yörükoğlu

Radical Prostatectomy and Lymphadenectomy in the High-Risk Prostate Cancer: Surgical Technique, Functional and Oncologic Outcomes

• Hayrettin Şahin
• Hasan Deliktaş

Early and Late Complications of Urinary Diversions after Radical Cystectomy

• Umut Gönülalan
• Murat Koşan

Active surveillance for localized prostate cancer

• İlker Tınay
• Levent Türkeri

Bladder Perforation During TUR of Non Muscle Invasive Bladder Tumours: Early and Late Management

• Deniz Arslan

Surgical technique of nerve sparing radical prostatectomy and periprostatic field anatomy

• Ali Cansu Bozacı
• Bülent Akdoğan
• Haluk Özen

Current Status of Laparoscopic Radical Nephroureterectomy in the Treatment Modalities for Upper Urinary Tract Tumors

• Ahmet Güdeloğlu
• Cenk Yücel Bilen

Relationship between active surveillance / watchfull waiting and quality of life in localised prostate cancer

• İlker Çelen
• Yasin Ceylan

Current surgical approaches in local invasive prostate cancer: urologist approach

• Zafer Kozacıoğlu
• Bülent Günlüsoy

How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?

• İlker Çelen
• Murat Lekili

The Status of Testicular Self-Examination in the Early Diagnosis of TesticularCancer: Conjuncture in the World and in Turkey

• Barış Kuzgunbay

Active Surveillance in Prostate Cancer

• Volkan İzol
• Nebil Akdoğan

Prostate Biopsy 2014: TRUS, MRI/TRUS Fusion? Transrectal? Transperineal?

• Kaan Çömez
• Ozan Bozkurt
• Mehmet Uğur Mungan

Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective

• Ömür Karakoyun Çelik

Radical prostatectomy indications and outcomes in the high-risk localised prostate cancer

• Hayrettin Şahin
• Hasan Deliktaş

Risk Factors and Etiology in Renal Cell Carcinoma

• Ümit Gül

Multiparametric MR in Prostate Cancer: General Practical Application Advices

• Seçil Mustafa
• Basara Işıl
• Altay Canan

Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy

• Ali Cansu Bozacı
• Sertaç Yazıcı

Management of infravesical strictures after radical retropubic prostatectomy

• Mustafa Karalar
• İbrahim Keleş
• Mutlu Ateş

Is there a role of intraoperative ultrasonography in decision of partial / total nephrectomy?

• Mustafa Seçil

AUA/ASTRO 2013 Guidelines for Adjuvant and Salvage Radiation Therapy After Prostatectomy: What are the Yields and the Changes?

• Deniz Yalman

Laparo-Endoscopic Single Site (LESS) radical prostatectomy: does port number decrease?

• Bircan Mutlu
• Volkan Tuğcu

The role of surgery in renal cell carcinoma metastasis

• Levent Mert Günay
• Mehmet Cemil Uygur

Prostate cancer in the era of robotic surgery

• Çag Çal

Society of Urooncology nomogram for kidney cancer – the user's manual

• Özgür Yaycıoğlu

Risk Factors for Urothelial Cancers

• Ümit Gül
• Barış Kuzgunbay

Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”

• Ender Özden
• Mehmet Necmettin Mercimek

Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?

• Gül Alço
• Sefik İğdem

Active Surveillance in Prostate Cancer: Can We Expand the Indications?

• Hacı Murat Akgül
• Asgar Garayev
• İlker Tinay

Postchemotherapy Retroperitoneal Lymph Node Dissection

• Burak Çıtamak
• Bülent Akdoğan
• Mesut Altan
• Haluk Özen

Nursing interventions in patients receiving Taxan Chemotherapy

• Yeter Kırdal

Most frequently seen side effects of targeted therapy: how to manage?

• Önder Kara
• Bülent Akdoğan

Current situation of the clinical stage I nonseminomatous germ cell testis tumour

• Alim Koşar
• Osman Ergün

The Current Radiological Approach to Renal Cell Carcinoma

• Nuray Voyvoda
• Bekir Voyvoda
• Ömür Memik

Follow-up principles after curative treatment in renal cancer

• Ercan Kazan
• Hakan Gemalmaz

Chemotherapy related adverse events in patients with testicular cancer

• Özgür Tanrıverdi
• Bülent Karabulut

Liquid Biopsy: Circulating Tumor Cells and its Impact on Follow-up/Treatment of Prostate Cancer Patients

• İbrahim Kulaç

Bosniak classification 2012 in renal cysts

• Gülgün Yılmaz Ovalı
• Gökhan Pekindil
• Serdar Tarhan

RCC and lymphadenectomy

• Serdar Çelik
• Ozan Bozkurt
• Uğur Mungan

Lymph Node Dissection and Adrenalectomy in Locally Advanced Renal Cell Carcinoma

• Burak Çitamak
• Emrullah Sögütdelen
• Bülent Akdogan

Active surveillence in small kidney tumors

• Yasin Ceylan
• Bülent Günlüsoy

Adrenal surgery: to whom and how?

• Yavuz Selim Süral
• Çağ Çal

Cytoreductive Nephrectomy in the Targeted Treatment Era

• Özgür Yaycioglu

Laparoscopic Simple Prostatectomy

• Kadir Ömür Günseren
• Yakup Kordan
• Hakan Vuruşkan

Laparoscopic adrenalectomy

• Ömer Demir
• Ozan Bozkurt
• Tevfik Demir

Impact of Renal Ischemia on Renal Failure After Partial Nephrectomy

• Yavuz Selim Süral
• Ahmet Çag Çal

Robot-assisted partial nephrectomy: step by step

• Alper Bitkin
• Volkan Tugcu

Management of Upper Urinary Tract Tumors: Comparative Oncological Evaluation of Radical Nephroureterectomy and Nephron Sparing Endoscopic Treatments

• Ali Tekin
• Alpaslan Yüksel

Open partial nephrectomy: recent situation

• İyimser Üre
• Sinan Sözen

Hemostatic agents in open partial nephrectomy

• Kemal Ener
• Emrah Okulu
• Önder Kayıgil

Robotic Prostatectomy: Is it More Advantageous Regarding Quality of Life?

• Olcay Yıldırım
• Kamil Çam

Current Situation in the Use of 5-Alpha Reductase Inhibitors for Prostatic Diseases

• Murat Koşan

Could We Reach the Standard Treatment of Lower Urinary Tract Symptoms/Benign Prostate Hyperplasia?

• Eray Hasırcı
• Murat Koşan

Minimally invasive treatments for upper urinary tract transitional epithelial carcinoma

• Mehmet Selçuk Keskin

Morphologic and Molecular Charecteristics of Renal Tumors

• Sait Şen

Monopolar and Bipolar Modalities of Transurethral Prostate Resection

• Hikmet Köseoğlu
• Ramazan Yavuz Akman

The Effects of Medical Treatments Used for Benign Prostatic Hyperplasia on Ejaculation

• Ali Kayıkçı
• Coşkun Kaçağan
• Ali Tekin

The Effects of Hormonal Therapy on Quality of Life in Prostate Cancer

• Yusuf Şenoğlu
• Kamil Çam

Quality Of Life

Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia

• Volkan Şen
• Ömer Demir
• Ahmet Adil Esen

Male lower urinary tract symptoms: An update – overactive bladder or not ?

• Tufan Tarcan
• İlker Tınay

Causes and treatment of postprostatectomy incontinence

• Bedreddin Seçkin
• Özcan Kılıç

BPH: The actual case and the future

• Cüneyt İşeri

How should we manage infertility in testicular cancer patients?

• Hakan Özveri
• Enis Rauf Coşkuner

What is the status of spouses in prostate cancer? Is their quality of life affected?

• Hakan Gemalmaz

Management of post radical retropubic prostatectomy incontinence

• Adnan Şimşir
• Gökhan Temeltaş

Can we prevent erectile dysfunction following radical prostatectomy? What are the medical and surgical alternatives?

• Cem Akbal
• Ferruh Şimsek

The impact of control cystoscopies' on quality of life in the surveillance of bladder tumor

• İlker Çelen

Does laser prostatectomy provide an advantage regarding quality of life?

• Olcay Yıldırım
• Kamil Çam

Bph

Metabolic syndrome in the etiology of benign prostatic hyperplasia/ lower urinary tract symptoms

• Polat Türker
• Cenk M. Yazıcı

Urodynamic studies in Benign Prostate Hyperplasia: whom and when?

• Umut Gönülalan
• Murat Koşan

The role of phosphodiesterase type-5 inhibitors in Benign Prostatic Hyperplasia, current approaches

• Eray Kemahlı
• Adnan Gücük
• Uğur Üyetürk

Will lasers replace transurethral resection of the prostate for the treatment of BPH?

• Ali Erol
• Serhat Dönmezer
• Erem Kaan Başok

Long-term treatment of Benign Prostatic Hyperplasia with the combination of alpha blockers and 5-alpha reductase inhibitors

• Cevahir Özer
• Mehmet İlteriş Tekin

Monopolar and bipolar transurethral prostate resection in surgical treatment of benign prostatic hyperplasia

• Eray Hasırcı
• Ayhan Dirim

Statin's role on protection from the benign prostatic hyperplasia and prostate cancer

• Eray Hasırcı
• A. İbrahim Oğuzülgen

Antimuscarinics in the treatment of overactive bladder: does one fit all? Can treatment be individualized?

• Ceyhun Özyurt

Robot assisted simple prostatectomy: is it rationale?

• Levent Mert Günay
• Mehmet Cemil Uygur

Does gastronomy effect the BPH risk? The relationship between BPH and obesity

• Serkan Demiryoguran
• Atilla Tan
• Gürhan Günaydin

Pathology

Evaluation of the non-neoplastic kidney in tumor nephrectomy specimens and its significance

• Ayşim Özağarı

General Urooncology

An approach to dermatological side effects of targeted therapies

• Cemal Bilaç
• Sedef Bayata
• Serap Öztürkcan

Does physical activity decrease incidence of urooncologic cancers?

• Evren Süer
• Çağatay Göğüs